Clinical Trial Update: Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial of vinflunine in combination with capecitabine for previously treated metastatic breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Vinflunine (vinflunine)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Breast Cancer | Phase 2 | Status: WITHDRAWN